Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Healthcare
Create a narrative
IDEXX Laboratories Community
NasdaqGS:IDXX Community
3
Narratives
written by author
0
Comments
on narratives written by author
43
Fair Values set
on narratives written by author
Create a narrative
IDEXX Laboratories
Popular
Undervalued
Overvalued
Community Investing Ideas
IDEXX Laboratories
AN
AnalystLowTarget
Consensus Narrative from 12 Analysts
Global Inequality And Regulatory Pressures Will Erode Diagnostic Prospects
Key Takeaways Competitive pressures, economic constraints, and client behavior shifts threaten IDEXX's pricing power, core market growth, and recurring revenue streams. Regulatory and operational cost increases, alongside innovation challenges, may compress margins and slow long-term earnings growth.
View narrative
US$385.00
FV
40.4% overvalued
intrinsic discount
7.56%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 14 hours ago
author updated this narrative
IDEXX Laboratories
AN
AnalystHighTarget
Consensus Narrative from 12 Analysts
Global Pet Trends Will Expand Advanced Diagnostic Markets
Key Takeaways Launches of advanced diagnostics platforms, software integration, and focus on preventive care are strengthening recurring revenue streams and deepening clinic relationships for long-term growth. Global expansion and increased pet healthcare spending, especially in emerging markets, are driving revenue diversification and enhancing margin stability through geographic spread.
View narrative
US$625.00
FV
13.5% undervalued
intrinsic discount
9.05%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 15 hours ago
author updated this narrative
IDEXX Laboratories
AN
AnalystConsensusTarget
Consensus Narrative from 12 Analysts
Early Canine Lymphoma Detection And AI Diagnostics Will Expand Markets
Key Takeaways IDEXX's strategic international expansion and innovation roadmap are poised to enhance diagnostic usage and tap into high-potential markets, driving sustainable revenue growth. Innovative product launches, including the IDEXX Cancer Dx and cloud-based solutions, are anticipated to boost recurring revenues by increasing diagnostic frequency and operational efficiency.
View narrative
US$519.99
FV
4.0% overvalued
intrinsic discount
7.91%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
19
users have followed this narrative
about 16 hours ago
author updated this narrative
Your Valuation for
IDXX
IDXX
IDEXX Laboratories
Your Fair Value
US$
Current Price
US$540.68
12.0% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
6b
2015
2018
2021
2024
2025
2027
2030
Revenue US$5.6b
Earnings US$1.3b
Advanced
Set Fair Value